Comparison of strategies to overcome the hypertensive effect of combretastatin-A4 phosphate in a rat model

被引：0
|
作者：
Honess, DJ
Hylands, F
Chaplin, DJ
Tozer, GM
机构：
[1] Oxigene Inc, Watertown, MA 02472 USA
[2] Mt Vernon Hosp, Gray Canc Inst, Tumor Microcirculat Grp, Northwood HA6 2JR, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S118 / S119
页数：2
相关论文
共 50 条
  • [1] Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor
    Dorr, RT
    Dvorakova, K
    Snead, K
    Alberts, DS
    Salmon, SE
    Pettit, GR
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (02) : 131 - 137
  • [2] Drug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effect
    Zhu, Jinfang
    Hu, Mengying
    Qiu, Liyan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (07) : 844 - 855
  • [3] Applying a Tripodal Hexaurea Receptor for Binding to an Antitumor Drug, Combretastatin-A4 Phosphate
    Kong, Yu
    Zhang, Rong
    Li, Boyang
    Zhao, Wei
    Wang, Ji
    Sun, Xiao-Wen
    Lv, Huihui
    Liu, Rui
    Tang, Juan
    Wu, Biao
    MATERIALS, 2024, 17 (11)
  • [4] Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure
    Ley, Carsten D.
    Horsman, Michael R.
    Kristjansen, Paul E. G.
    NEOPLASIA, 2007, 9 (02): : 108 - 112
  • [5] Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma
    Zhu, Jinfang
    Xu, Xiaoping
    Hu, Mengying
    Qiu, Liyan
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (06) : 997 - 1006
  • [6] STRUCTURAL AND BIOCHEMICAL-COMPARISON OF THE ANTI-MITOTIC AGENTS COLCHICINE, COMBRETASTATIN-A4 AND AMPHETHINILE
    MCGOWN, AT
    FOX, BW
    ANTI-CANCER DRUG DESIGN, 1989, 3 (04): : 249 - 254
  • [7] Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model
    Gao, Meng
    Zhang, Dongjian
    Jin, Qiaomei
    Jiang, Cuihua
    Wang, Cong
    Li, Jindian
    Peng, Fei
    Huang, Dejian
    Zhang, Jian
    Song, Shaoli
    ONCOTARGET, 2016, 7 (36) : 58133 - 58141
  • [8] A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
    Siemann, Dietmar W.
    Chaplin, David J.
    Walicke, Patricia A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 189 - 197
  • [9] Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats
    Ke, Qingen
    Bodyak, Natalya
    Rigor, Debra L.
    Hurst, Nicole W.
    Chaplin, David J.
    Kang, Peter M.
    VASCULAR PHARMACOLOGY, 2009, 51 (5-6) : 337 - 343
  • [10] Antitumor Drug Combretastatin-A4 Phosphate Aggravates the Symptoms of Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
    Tang, Zhengshan
    Xiong, Dehui
    Song, Jianhui
    Ye, Mao
    Liu, Jing
    Wang, Zi
    Zhang, Lei
    Xiao, Xiaojuan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345